Afreen Khan

404 total citations
10 papers, 294 citations indexed

About

Afreen Khan is a scholar working on Molecular Biology, Oncology and Molecular Medicine. According to data from OpenAlex, Afreen Khan has authored 10 papers receiving a total of 294 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 2 papers in Oncology and 2 papers in Molecular Medicine. Recurrent topics in Afreen Khan's work include CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Afreen Khan is often cited by papers focused on CRISPR and Genetic Engineering (2 papers), CAR-T cell therapy research (2 papers) and Retinoids in leukemia and cellular processes (2 papers). Afreen Khan collaborates with scholars based in India, Malaysia and Saudi Arabia. Afreen Khan's co-authors include Sarita Bajaj, Nafees Ahemad, Sirajudheen Anwar, Sakeel Ahmed, Jonaid Ahmad Malik, Aisha Sheikh, Abbas Ali Mahdi, Fauzia Mohsin, Jalees Fatima and Kishwar Azad and has published in prestigious journals such as Therapeutic Delivery, Indian Journal of Endocrinology and Metabolism and BMJ Case Reports.

In The Last Decade

Afreen Khan

10 papers receiving 288 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Afreen Khan India	6	90	76	53	49	39	10	294
Ahmed I. Yousef Egypt	9	92 1.0×	79 1.0×	55 1.0×	42 0.9×	40 1.0×	14	343
Swaraj Bandhu Kesh India	10	47 0.5×	115 1.5×	52 1.0×	43 0.9×	53 1.4×	13	371
Jung-In Choi South Korea	9	74 0.8×	114 1.5×	45 0.8×	35 0.7×	37 0.9×	15	377
Nelson Andrade Portugal	13	81 0.9×	122 1.6×	52 1.0×	44 0.9×	37 0.9×	38	379
Haijun Xiong China	6	71 0.8×	122 1.6×	60 1.1×	33 0.7×	59 1.5×	7	353
Vanktesh Kumar India	4	133 1.5×	94 1.2×	45 0.8×	42 0.9×	69 1.8×	7	379
Vânia Ortega Gutierres Brazil	8	131 1.5×	100 1.3×	53 1.0×	64 1.3×	29 0.7×	10	374
Mariangela Di Giacomo Italy	10	57 0.6×	146 1.9×	44 0.8×	49 1.0×	46 1.2×	11	464
Gholamreza Dehghanzadeh Iran	5	79 0.9×	96 1.3×	25 0.5×	34 0.7×	33 0.8×	7	380
Luis V. Herrera‐Marcos Spain	9	50 0.6×	123 1.6×	46 0.9×	41 0.8×	36 0.9×	16	387

Countries citing papers authored by Afreen Khan

Since Specialization

Citations

This map shows the geographic impact of Afreen Khan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Afreen Khan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Afreen Khan more than expected).

Fields of papers citing papers by Afreen Khan

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Afreen Khan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Afreen Khan. The network helps show where Afreen Khan may publish in the future.

Co-authorship network of co-authors of Afreen Khan

This figure shows the co-authorship network connecting the top 25 collaborators of Afreen Khan. A scholar is included among the top collaborators of Afreen Khan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Afreen Khan. Afreen Khan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Khan, Afreen, et al.. (2024). Synergistic Anticancer Efficacy of Curcumin and Doxorubicin Combination Treatment Inducing S-phase Cell Cycle Arrest in Triple-Negative Breast Cancer Cells: An In Vitro Study. Cureus. 16(12). e75047–e75047. 3 indexed citations

Khan, Afreen, et al.. (2024). The combination of Curcumin and Doxorubicin on targeting PI3K/AKT/mTOR signaling pathway: an in vitro and molecular docking study for inhibiting the survival of MDA-MB-231. In Silico Pharmacology. 12(2). 58–58. 8 indexed citations

Khan, Afreen, Esha Sarkar, Anu Chandra, et al.. (2024). Serum Insulin, Insulin-Like Growth Factor-1, Testosterone and Lipid Profile Levels in Benign Prostatic Hyperplasia and Prostate Cancer at Diagnosis. Cureus. 16(12). e75342–e75342. 1 indexed citations

Malik, Jonaid Ahmad, et al.. (2023). Nano-drug Delivery System: a Promising Approach Against Breast Cancer. Therapeutic Delivery. 14(5). 357–381. 30 indexed citations

Khan, Afreen, et al.. (2022). CRISPR/Cas9 encouraged CAR-T cell immunotherapy reporting efficient and safe clinical results towards cancer. Cancer Treatment and Research Communications. 33. 100641–100641. 15 indexed citations

Khan, Afreen, et al.. (2021). Erratic journey of CRISPR/Cas9 in oncology from bench-work to successful-clinical therapy. Cancer Treatment and Research Communications. 27. 100289–100289. 9 indexed citations

Khan, Afreen, Anu Chandra, Abbas Ali Mahdi, & Satyanarayan Sankhwar. (2019). PROSTATE CANCER AND DIABETES LINK: ROLE OF INSULIN AND INSULIN LIKE GROWTH FACTORS. 6(2). 147–151. 3 indexed citations

Ahmad, Mehtab, et al.. (2013). Hydranencephaly: a rare cause of delayed developmental milestones. BMJ Case Reports. 2013. bcr2013009589–bcr2013009589. 1 indexed citations

Bajaj, Sarita, Afreen Khan, Aisha Sheikh, et al.. (2012). South Asian consensus statement on women′s health and Ramadan. Indian Journal of Endocrinology and Metabolism. 16(4). 508–508. 25 indexed citations

10.

Bajaj, Sarita & Afreen Khan. (2012). Antioxidants and diabetes. Indian Journal of Endocrinology and Metabolism. 16(8). 267–267. 199 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact